Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Licartin plus TACE for prevention of recurrence in unresectable hepatocellular carcinoma
ChiCTR-ONRC-11001664Phase 4Recruiting
- Sponsor
- Air Force Medical University
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of licofelone in hepatocellular carcinoma (HCC) (2 arms), sponsored by Air Force Medical University. Primary endpoints: Time to tumor progression and Recurrence rate. Started Nov 2011; status: recruiting.
02
Drugs
licofelone
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on ChiCTR-ONRC-11001664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-11001664.